Environmental tobacco smoke suppresses nuclear factor-kappaB signaling to increase apoptosis in infant monkey lungs

Cai-Yun Zhong1, Ya Mei Zhou, Jesse P Joad

  • 1Center for Health and the Environment, University of California, Old Davis Road, Davis, CA 95616, USA.

Abstract

Insights

Environmental tobacco smoke exposure in infant monkeys suppresses the NF-kappaB survival pathway, increasing lung cell apoptosis. This suggests a mechanism for impaired lung development and potential long-term respiratory issues.

Area of Science:

  • Pulmonary Medicine
  • Developmental Biology
  • Toxicology

Background:

  • Early-life exposure to environmental tobacco smoke (ETS) adversely impacts lung development.
  • The precise molecular mechanisms driving pulmonary apoptosis due to ETS remain unclear.

Purpose of the Study:

  • To elucidate the role of the nuclear factor kappa B (NF-kappaB) pathway in neonatal lung development under ETS exposure.
  • Investigate NF-kappaB's function as a critical cell survival pathway in the context of ETS.

Main Methods:

  • Timed-pregnant rhesus monkeys and offspring were exposed to filtered air or diluted cigarette smoke (ETS surrogate).
  • Exposure occurred from gestational age 45-50 days to postnatal age 72-77 days.
  • Lung tissue analysis included NF-kappaB DNA binding activity, apoptosis markers, and related gene expression.

Main Results:

  • ETS exposure significantly inhibited the NF-kappaB activation pathway and its DNA binding activity.
  • Down-regulation of NF-kappaB-dependent anti-apoptotic genes was observed.
  • Increased caspase activation and apoptosis rates were detected in lung parenchyma, while AP-1, p53, and Akt activities remained unchanged.

Conclusions:

  • Low-level ETS exposure during neonatal development in nonhuman primates can disrupt lung maturation.
  • NF-kappaB plays a crucial role in regulating the apoptotic process in the developing lung.
  • These findings highlight potential implications for compromised lung growth and function in later life.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...